The approved injection therapy Kesimpta (ofatumumab) is generally safe and helps most adults with relapsing forms of multiple sclerosis (MS) keep their disease stable over time with few or no relapses, a real-world study has found. The data show treatment is especially effective when started at a younger…
Discussion
Because multiple sclerosis (MS) is so unpredictable, many of us experience a silent battle of grieving what was, while simultaneously navigating what will become of our lives. It might seem to an outsider that the sorrow comes from mourning only the loss of major milestones, but we also deal…
Discussion
Differences in gut bacteria may affect how people with multiple sclerosis (MS) respond to dietary interventions, according to a study. The researchers stressed that their analysis was limited to data from a small group of people, so further studies will be needed to validate and expand on the results.
Discussion
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Quantum Biopharma’s application seeking clearance to begin a Phase 2 trial testing Lucid-MS in people with multiple sclerosis (MS). Quantum said the FDA requested further information before clearing the investigational new drug (IND) application and…
Discussion
A new formulation of Briumvi (ublituximab) — TG Therapeutics’ therapy for relapsing forms of multiple sclerosis (MS) — designed for possible at-home self-injection was generally well tolerated and showed biological activity consistent with the approved intravenous (into-the-vein) version, according to Phase 1 trial data. The Phase 1 trial is…
Get regular updates to your inbox.
